IL-8-stimulated expression of urokinase-type plasminogen activator in human skin and human epidermal cells

Journal of Surgical Research

Volumn 106, Issue 2, 2002, Pages 328-334

  Han, Yuan Ping ^a   Hughes, Michael W ^a   Nien, Yih Dar ^a   Garner, Warren L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Dermal fibroblast; Epidermal; IL 8; Induction; Interleu kin 8; Keratinocytes; Plasminogen activator; Skin; uPA

Indexed keywords

CYTOKINE; FIBRIN; INTERLEUKIN 8; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DERMIS; DNA FLANKING REGION; DRUG POTENCY; ENZYME INDUCTION; EPIDERMIS CELL; EXTRACELLULAR MATRIX; FIBRINOLYSIS; FIBROBLAST; GENE ACTIVATION; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MEDIATOR; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REPORTER GENE; SKIN; SKIN CULTURE; TRANSACTIVATION;

EID: 0036386991     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2002.6482     Document Type: Article

References (31)

1. Woodley, D. T., O'Keefe, E. J., and Prunieras, M. Cutaneous wound healing: A model for cell-matrix interactions. J. Am. Acad. Dermatol. 12: 420, 1985.
2. Martin, P. Wound healing - Aiming for perfect skin regeneration. Science 276: 75, 1997.
3. Iocono, J. A., Colleran, K. R., Remick, D. G., et al. Interleukin-8 levels and activity in delayed-healing human thermal wounds. Wound Repair Regen. 8: 216, 2000.
4. Garner, W. L., Karmiol, S., Rodriguez, J. L., et al. Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J. Invest. Dermatol. 101: 875, 1993.
5. Matrisian, L. M. The matrix-degrading metalloproteinases. Bioessays 14: 455, 1992.
6. Andreasen, P. A., Kjoller, L., Christensen, L., et al. The urokinase-type plasminogen activator system in cancer metastasis: A review. Int. J. Cancer 72: 1, 1997.
7. Collen, D., and Lijnen, H. R. Fibrin-specific fibrinolysis. Ann. N.Y. Acad. Sci. 667: 259, 1992.
8. Dano, K., Romer, J., Nielsen, B. S., et al. Cancer invasion and tissue remodeling - Cooperation of protease systems and cell types. APMIS 107: 120, 1999.
9. Goretzki, L., Schmitt, M., Mann, K., et al. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L. FEBS Lett. 297: 112, 1992.
10. Sprengers, E. D., and Kluft, C. Plasminogen activator inhibitors. Blood 69: 381, 1987.
11. Bugge, T. H., Flick, M. J., Danton, M. J., et al. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 93: 5899, 1996.
12. Carmeliet, P., Schoonjans, L., Kieckens, L., et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419, 1994.
13. Baird, J., Lazarus, G. S., Belin, D., et al. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J. Invest. Dermatol. 95: 548, 1990.
14. Rogers, A. A., Burnett, S., Lindholm, C., et al. Expression of tissue-type and urokinase-type plasminogen activator activities in chronic venous leg ulcers. Vasa 28: 101, 1999.
15. Romer, J., Lund, L. R., Eriksen, J., et al. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J. Invest. Dermatol. 97: 803, 1991.
16. Grondahl-Hansen, J., Lund, L. R., Ralfkiaer, E., et al. Urokinase- and tissue-type plasminogen activators in keratin-ocytes during wound reepithelialization in vivo. J. Invest. Dermatol. 90: 790, 1988.
17. Niedbala, M. J., and Stein, M. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells. Biomed. Biochim. Acta 50: 427, 1991.
18. Gerwin, B. I., Keski-Oja, J., Seddon, M., et al. TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells. Am. J. Physiol. 259: L262, 1990.
19. Stacey, M. C., Burnand, K. G., Mahmoud-Alexandroni, M., et al. Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers. Br. J. Surg. 80: 596, 1993.
20. Rodriguez, J. L., Miller, C. G., Garner, W. L., et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J. Trauma 34: 684, 1993.
21. Han, Y. P., Tuan, T. L., Wu, H., et al. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J. Cell Sci. 114: 131, 2001.
22. Han, Y. P., Tuan, T. L., Hughes, M., et al. Transforming growth factor-beta- and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin. J. Biol. Chem. 276: 22341, 2001.
23. Gum, R., Wang, S. W., Lengyel, E., et al. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. Anticancer Res. 15: 1167, 1995.
24. Vassalli, J. D., Wohlwend, A., and Belin, D. Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: A localized and regulated proteolytic system. Curr. Topics Microbiol. Immunol. 181: 65, 1992.
25. Medcalf, R. L., Richards, R. I., Crawford, R. J., et al. Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. EMBO J. 5: 2217, 1986.
26. Beers, W. H., Strickland, S., and Reich, E. Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation. Cell 6: 387, 1975.
27. Liu, W. K., Burleigh, B. D., and Ward, D. N. Steroid and plasminogen activator production by cultured rat granulosa cells in response to hormone treatment. Mol. Cell. Endocrinol. 21: 63, 1981.
28. Wojta, J., Zoellner, H., Gallicchio, M., et al. Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro. Lymphokine Cytokine Res. 13: 133, 1994.
29. Georg, B., Helseth, E., Lund, L. R., et al. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines. Mol. Cell. Endocrinol. 61: 87, 1989.
30. van Hinsbergh, V. W., van den Berg, E. A., Fiers, W., et al. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 75: 1991, 1990.
31. Bechtel, M. J., Reinartz, J., Rox, J. M., et al. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha. Exp. Cell Res. 223: 395, 1996.